SCA
PEARW

Sandy Cove Advisors’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Sandy Cove Advisors’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33
Closed – – 416
2022
Q1 		$0 Buy
+33
New +$23 ﹤0.01% 448

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Sandy Cove Advisors's PEARW Position: Q2 2022 in Review

Sandy Cove Advisors sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2022, closing a stake of 33 shares.

Sandy Cove Advisors first reported a position in PEARW in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 37 funds tracked by Wall St. Rank hold PEARW as of Q2 2022.

  • Sandy Cove Advisors reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
  • Sandy Cove Advisors sold 33 Pear Therapeutics, Inc. Warrant shares in Q2 2022.
  • Sandy Cove Advisors first reported a position in Pear Therapeutics, Inc. Warrant in Q1 2022 and held it in 1 quarter.
  • Sandy Cove Advisors's Pear Therapeutics, Inc. Warrant position peaked at $0 in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2022.

Based on Sandy Cove Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.